Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a commercial vehicle production update for its Class 3 EV cab chassis trucks and Class 1 EV cargo vans. According to the report, the company is on track to produce 150 Class 3 EV trucks through December 2023 and to begin production and…
FingerMotion (NASDAQ: FNGR), a mobile services and data company, today released its financial results for the second quarter of fiscal 2024 for the period ended Aug. 31, 2023. Among the highlights, the company reported quarterly revenue of $9.28 million (includes SMS & MMS, telecommunications products and services businesses, and big data), reflecting an increase of…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is spotlighted in a recent article focused on glioblastoma, the most aggressive type of brain cancer. Noting that glioblastoma has an average survival of only 14 to 16 months after diagnosis,…
Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, has sealed a deal with mixed martial arts (“MMA”) superstar Jorge Masvidal. The agreement calls for Masvidal to serve as brand ambassador for Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity.…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that its crime-fighting tech portfolio is expanding with the addition of the K1 Hemisphere. According to the announcement, the K1 is the company’s smallest machine to date. The new ASR carries the slogan: Half a World…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has granted a new global, exclusive license to SulfoSyn Limited; the license is for the exclusive global use of all nonpharmaceutical applications of Lexaria’s proprietary DehydraTECH-sulforaphane, including the right to authorize sublicenses. According to the announcement, Lexaria has already received an up-front cash payment,…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is continuing to add to its list of valued clients. The company has secured two more contracts for its K5 ASR, including a hotel in Athens, Georgia, and a Pre-K school in Vancouver, Washington. According to the announcement, the hospitality…
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, was in the spotlight during a recent interview released by The Watchlist by The Market Herald. During the interview, The Watchlist’s Ryan Dhillon talked with Mark Selby, Canada Nickel’s president and CEO. The two discussed the company’s recent…
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that, through a new e-commerce distribution agreement, it will enable the online sales of OPKO Health Europe, a subsidiary of OPKO Health (NASDAQ: OPK) products in China. Under the agreement terms, NextPlat will launch a OPKO Health-branded online storefront on Alibaba Group Holding Limited’s (NYSE:…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced two new sales for its K5 ASRs and an expansion sale from an existing user of its K1B line of emergency communication systems. The announcement reads, “Two Portland, Oregon, hotels each signed contracts for Knightscope ASRs to…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has been granted two new patents by the Canadian Intellectual Property Office (“CIPO”), increasing its portfolio to 37 granted patents. According to the update, Canadian Patent #2,984,917, “ Stable Ready-to-drink Beverage Compositions Comprising Lipophilic Active Agents, ” was granted…
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today released results from the bankable feasibility study (“BFS”) for its innovative and wholly owned Crawford Nickel Sulphide Project (“Crawford”). According to the announcement, the results confirm significantly improved economics from its preliminary economic analysis (“PEA”), with an after-tax NPV 8% of $2.5 billion and IRR of 17.1%. Ausenco…
RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults, has announced a prepackaged reorganization of some of its subsidiaries. Those subsidiaries include RevitaLid Pharmaceutical Corp., RVL Pharmaceuticals Inc. and RVL Pharmacy, LLC. According…
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, is working with Satispay, the leading Italian fintech unicorn revolutionizing mobile payments. The two companies have built a quantum-hybrid application designed to optimize customer rewards initiatives. According to the announcement, the quantum-optimized rewards…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting enrollment of 229 participants in its ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent GBM, an aggressive and incurable form of brain cancer; the company expects…
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today announced that it will host a webcast and conference call at 11:00 a.m. Eastern Time on Thursday, Oct. 12, 2023, to discuss the definitive feasibility study for its Crawford Nickel Sulphide Project. Interested parties should visit https://ibn.fm/WYNyd to register for the event and access the webcast and join…
Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, today announced the appointment of Leni Boeren and Ruud Hendriks as independent directors. Both Boeren and Hendriks bring extensive, high-level experience in finance and business. Boeren has a 40-year career in the financial…
PaxMedica (NASDAQ: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions, today announced its Gold Sponsorship of The BRAIN Foundation’s esteemed Synchrony Symposia 2023. The globally recognized event serves as a catalyst for translational research in…
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is featured in the latest Bell2Bell Podcast release. During the segment, podcast host Stuart Smith discusses the company with Clene president and CEO Rob Etherington, who explains Clene’s business model and provides an overview…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced new purchase orders. The orders are from four existing customers – two cities and two universities – seeking to grow and improve their emergency communications systems. The announcement reads, “Advocates, individuals and government officials at all levels…